Literature DB >> 35601952

Cardiac tamponade - an unexpected "long COVID-19" complication.

Cristian Cobilinschi1, Oana Maria Melente2, Cristina Bologa2, Ana-Maria Cotae2, Laura Constantinescu2, Sonia Bacruban2, Ioana Marina Grinţescu1.   

Abstract

Introduction: Year 2020 has been a cornerstone in medical research due to the COVID-19 pandemic outbreak. The process of understanding the condition brought to light certain organ involvement like pulmonary or kidney damage or endocrine disbalances, while connection to other types of organ impairment remain unclear. SARS-CoV-2 has previously been incriminated in cardiac involvement, ranging from mild symptoms to more severe occurrences such as myocarditis, arrythmias or heart failure, thus complicating the acute-phase management and worsening patients' prognosis. Despite being reported as an acute manifestation in critical COVID-19, cardiac tamponade seems to also occur as a "long- COVID19" complication. The latter is a distinct yet unclear entity associated with remanent fatigue or cough, but more severe sequelae like vasculitis or polyneuropathy can occsur. Case report: We report the case of a 42-year-old patient admitted in the intensive care unit for severe respiratory and renal dysfunction one month after an initial mild episode of COVID-19. RT-PCR for SARS-CoV-2 on admission was negative. Initial imaging through CT and heart ultrasound revealed the presence of pericardial effusion but no signs of tamponade were initially obvious. Twelve hours later, the patient's state deteriorated with cardiocirculatory failure and signs of obstructive shock. Agents responsible for severe acute respiratory infection (SARI) such as influenza A and B, adenovirus, Bordetella pertussis, Mycoplasma pneumoniae, coxsackie virus, Chlamydia pneumoniae or parainfluenza viruses were ruled out. Surprisingly, RT-PCR testing for SARS-CoV-2 came back positive, although the initial test was negative. Repeated imaging confirmed massive circumferential pericardial effusion for which emergency pericardiocentesis was performed. Fluid was an exudate and histopathology reported chronic inflammation. RT-PCR testing for Mycoplasma tuberculosis in the pericardial tissue came back negative. Conclusions: The case is to our knowledge among the first to report cardiac tamponade one month after mild COVID-19 infection. The aim of this case report is to raise awareness in the medical community on the possibility of severe complications targeting major organs in the long-COVID-19 phase. GERMS.

Entities:  

Keywords:  COVID-19; cardiac tamponade; late COVID; obstructive shock; pericardial effusion; pericardiocentesis; viral pericarditis

Year:  2022        PMID: 35601952      PMCID: PMC9113679          DOI: 10.18683/germs.2022.1313

Source DB:  PubMed          Journal:  Germs        ISSN: 2248-2997


  10 in total

1.  Pericarditis in patients with coronavirus disease 2019: a systematic review.

Authors:  Carlos Diaz-Arocutipa; Jose Saucedo-Chinchay; Massimo Imazio
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2021-04-28       Impact factor: 2.160

2.  Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19).

Authors:  Riccardo M Inciardi; Laura Lupi; Gregorio Zaccone; Leonardo Italia; Michela Raffo; Daniela Tomasoni; Dario S Cani; Manuel Cerini; Davide Farina; Emanuele Gavazzi; Roberto Maroldi; Marianna Adamo; Enrico Ammirati; Gianfranco Sinagra; Carlo M Lombardi; Marco Metra
Journal:  JAMA Cardiol       Date:  2020-07-01       Impact factor: 14.676

Review 3.  Extrapulmonary manifestations of COVID-19.

Authors:  Aakriti Gupta; Mahesh V Madhavan; Kartik Sehgal; Nandini Nair; Shiwani Mahajan; Tejasav S Sehrawat; Behnood Bikdeli; Neha Ahluwalia; John C Ausiello; Elaine Y Wan; Daniel E Freedberg; Ajay J Kirtane; Sahil A Parikh; Mathew S Maurer; Anna S Nordvig; Domenico Accili; Joan M Bathon; Sumit Mohan; Kenneth A Bauer; Martin B Leon; Harlan M Krumholz; Nir Uriel; Mandeep R Mehra; Mitchell S V Elkind; Gregg W Stone; Allan Schwartz; David D Ho; John P Bilezikian; Donald W Landry
Journal:  Nat Med       Date:  2020-07-10       Impact factor: 53.440

4.  Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments.

Authors:  Shin Jie Yong
Journal:  Infect Dis (Lond)       Date:  2021-05-22

5.  Cardiac Tamponade Secondary to COVID-19.

Authors:  Mohammed F Dabbagh; Lindsey Aurora; Penny D'Souza; Allison J Weinmann; Pallavi Bhargava; Mir B Basir
Journal:  JACC Case Rep       Date:  2020-04-23

6.  SARS-CoV-2 detection in the pericardial fluid of a patient with cardiac tamponade.

Authors:  Andrea Farina; Giuseppe Uccello; Marta Spreafico; Giorgio Bassanelli; Stefano Savonitto
Journal:  Eur J Intern Med       Date:  2020-04-23       Impact factor: 4.487

7.  Pericardial effusion in patients with COVID-19: case series.

Authors:  François Sauer; Charlotte Dagrenat; Philippe Couppie; Gaelle Jochum; Pierre Leddet
Journal:  Eur Heart J Case Rep       Date:  2020-09-09

Review 8.  ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19.

Authors:  Mengzhen Dong; Jie Zhang; Xuefeng Ma; Jie Tan; Lizhen Chen; Shousheng Liu; Yongning Xin; Likun Zhuang
Journal:  Biomed Pharmacother       Date:  2020-08-24       Impact factor: 6.529

9.  Symptomatic pericardial effusion in the setting of asymptomatic COVID-19 infection: A case report.

Authors:  Behzad Amoozgar; Varun Kaushal; Umair Mubashar; Shuvendu Sen; Shakeel Yousaf; Matthew Yotsuya
Journal:  Medicine (Baltimore)       Date:  2020-09-11       Impact factor: 1.889

10.  The Clinical and Chest CT Features Associated With Severe and Critical COVID-19 Pneumonia.

Authors:  Kunhua Li; Jiong Wu; Faqi Wu; Dajing Guo; Linli Chen; Zheng Fang; Chuanming Li
Journal:  Invest Radiol       Date:  2020-06       Impact factor: 10.065

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.